1. Can intrahepatic shunting be measured?

   • Susanne Keiding

   Editorial Pages: 1185 - 1188

2. Introduction

   • T. R. Weihrauch

   EditorialNotes Pages: 4S - 4S

3. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting

   • Gianpaolo Molino
   • Paolo Avagnina
   • Cesare Fava

   Original Articles Pages: 1189 - 1196

4. Infusion manometry and detection of sphincteric function of crural diaphragm

   • Ravinder K. Mittal

   Part I: Methods Pages: 6S - 13S

5. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis

   • Carlo Merkel
   • Angelo Gatta
   • Arturo Ruol

   Original Articles Pages: 1197 - 1203

6. Esophageal manometry

   • L. M. A. Akkermans

   Part I: Methods Pages: 14S - 16S

7. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy

   • Oliviero Riggio
   • Franco Ariosto
   • Livio Capocaccia

   Original Articles Pages: 1204 - 1208

8. Discussion

   Part I: Methods Pages: 17S - 22S

9. Low serum levels of α-interferon, γ-interferon, and interleukin-2 in alcoholic cirrhosis

   • M. M. Vicente-Gutiérrez
   • A. Diez Ruiz
   • F. Gutiérrez Gea

   Original Articles Pages: 1209 - 1212

10. Summary & conclusion

    • G. Lux

    Part I: Methods Pages: 23S - 23S

11. Suppressor T-cell deficiency in primary sclerosing cholangitis

    • Alan E. Kilby
    • Edward L. Krawitt
    • Alex John

    Original Articles Pages: 1213 - 1216

12. Device dependent problems in esophageal manometry

    • M. Jakubowicz
    • M. Wienbeck
    • J. Barnert

    Part II: Standardization of the Procedure Pages: 25S - 28S

13. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant α-interferon for chronic non-A, non-B hepatitis

    • Masao Omata
    • Yoshimi Ito
    • Kunio Okuda

    Original Articles Pages: 1217 - 1222

14. Safety aspects of ambulant esophageal manometry and pH monitoring

    • Hans S. Merki
    • Clive H. Wilder-Smith
    • Joachim Gross

    Part II: Standardization of the Procedure Pages: 29S - 32S

15. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure

    • Jorge Rakela
    • James W. Mosley
    • The Acute Hepatic Failure Study Group

    Original Articles Pages: 1223 - 1228

16. Standardization of procedure of esophageal manometry

    • J. Janssens
    • G. Vantrappen

    Part II: Standardization of the Procedure Pages: 33S - 36S

17. Incidence of ultrasound-detected intrahepatic hematomas due to Tru-cut needle liver biopsy

    • Shigeo Sugano
    • Yasukiyo Sumino
    • Tohru Abei

    Original Articles Pages: 1229 - 1233

18. Esophageal stimulation tests

    • Hans-Dieter Janisch
    • Detlef von Kleist

    Part II: Standardization of the Procedure Pages: 37S - 41S

19. Hepatic lesions in alcoholic HBV carriers

    • Toru Takahashi
    • Tomoteru Kamimura
    • Fumihiro Ichida

    Original Articles Pages: 1234 - 1242

20. Discussion

    Part II: Standardization of the Procedure Pages: 42S - 47S

21. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension

    • Stephen H. Thomas
    • Takashi Joh
    • Joseph N. Benoit

    Original Articles Pages: 1243 - 1248

22. Summary & conclusion

    • Georg Stacher

    Part II: Standardization of the Procedure Pages: 48S - 49S

23. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia

    • M. Lémann
    • J. P. Dederding
    • R. Jian

    Original Articles Pages: 1249 - 1254

24. Which drugs should be studied by pharmacomanometry?

    • J. Kuhlmann
    • I. Konrad-Dalhoff
    • T. R. Weihrauch

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 51S - 61S

25. Idiopathic gastroparesis in patients with unexplained nausea and vomiting

    • Dov Wengrower
    • Samuel Zaltzman
    • Eran Goldin

    Original Articles Pages: 1255 - 1258

26. Value of esophageal pharmacomanometry (EPM) for evaluation of drug effects in man

    • T. R. Weihrauch
    • A. R. Baunack

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 62S - 65S

27. Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally

    • G. Stacher
    • G. V. Granser
    • J. Höbart

    Original Articles Pages: 1259 - 1265

28. Drug effects on esophageal smooth muscle

    • Anne Rühl
    • Joachim F. Erckenbrecht

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 66S - 77S

29. Mucosal humoral immune response toHelicobacter pylori in patients with duodenitis

    • J. E. Crabtree
    • T. M. Shallcross
    • M. S. Losowsky

    Original Articles Pages: 1266 - 1273

30. Influence of migrating motor complex on esophageal motility

    • I. Konrad-Dalhoff
    • A. R. Baunack
    • J. Kuhlmann

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 78S - 83S

31. Effects of verapamil and diltiazem on gastric emptying in normal subjects

    • Robert T. Yavorski
    • Scott E. Hallgren
    • Peter W. Blue

    Original Articles Pages: 1274 - 1276

32. Discussion

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 84S - 87S

33. Neutrophil chemotaxis in gastric mucosa

    • R. Kozol
    • A. Domanowski
    • R. Calzada

    Original Articles Pages: 1277 - 1280

34. Summary & conclusion

    • F. Baldi

    Part III: Drug Effects on Esophageal Smooth Muscle Pages: 88S - 88S

35. Structural and functional aspects of regeneration of human liver

    • Fenton Schaffner

    Conference Report Pages: 1282 - 1286

36. Computer-assisted ambulatory long-term manometry of tubular esophagus

    • Carsten Emde
    • David Armstrong
    • André L. Blum

    Part IV: New Technologies Pages: 90S - 97S

37. Cirrhosis of the liver

    • Francesco Callea
    • Massimo Brisigotti
    • M. Favret

    Conference Report Pages: 1287 - 1293

38. Combined 24-hour recording of esophageal pH and pressure

    • André J. P. M. Smout
    • Ronald Breumelhof

    Part IV: New Technologies Pages: 98S - 103S

39. Chronic mitoinhibition during promotion of hepatocarcinogenesis

    • Ezio Laconi
    • Prema M. Rao
    • Dittakavi S. R. Sarma

    Conference Report Pages: 1294 - 1298

40. Discussion

    Part IV: New Technologies Pages: 104S - 106S

41. Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC)

    • Antonio Francavilla
    • Carmine Panella
    • Thomas E. Starzl

    Conference Report Pages: 1299 - 1302

42. Summary & conclusion

    • S. Boesby

    Part IV: New Technologies Pages: 107S - 107S

43. Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver

    • Patricia K. Eagon
    • Antonio Francavilla
    • Thomas E. Starzl

    Conference Report Pages: 1303 - 1308

44. Summary

    • H. -D. Janisch

    Report Pages: 108S - 108S

45. Hepatic regeneration

    • David H. Van Thiel
    • Rudolf Stauber
    • Antonio Francavilla

    Conference Report Pages: 1309 - 1312

46. Acknowledgment

    Acknowledgments Pages: 109S - 109S

47. Prolactin-provoked alterations of cytosolic, membrane, and nuclear protein kinase C following partial hepatectomy

    • Arthur R. Buckley
    • Paul D. Crowe
    • Charles W. Putnam

    Conference Report Pages: 1313 - 1319

48. Hepatocyte transplantation

    • Achilles A. Demetriou
    • Andrew Felcher
    • Albert D. Moscioni

    Conference Report Pages: 1320 - 1326

49. Artificial liver

    • Tsuyoshi Takahashi
    • Paul S. Malchesky
    • Yukihiko Nosé

    Conference Report Pages: 1327 - 1340

50. Intragastric pH monitoring is unsuitable for diagnosis of duodenogastric reflux

    • J. Hostein
    • R. Bost
    • Paola Loria

    Letters to the Editor Pages: 1341 - 1343